CoLab Session:
A New Frontier for Discovery – How 3D genomics reveals novel disease mechanisms and therapeutic targets missed by other technologies
Thursday, October 27, 2022 | 4:30 pm – 5:00 pm
CoLab Theater 3
Join us to learn how 3D genomics is enabling biomarker discovery, tumor classification, and patient stratification. In this session, Kristin Sikkink, PhD, Senior Scientist at Arima Genomics, will share product updates and examples of how 3D genomics is revealing genetic drivers of previously undiagnosed tumors, reshaping how we understand disease, and producing exciting new opportunities in cancer research and beyond.
Register Now
Stop by our Poster Sessions:
Uncovering gene fusions with 3D genomics: from clinical validation to actionable insights for undiagnosable solid tumors*
Anthony Schmitt, PhD, SVP of Science
Wednesday, October 26 | 3:00 pm – 4:45 pm
Poster Location: PB1223 | Exhibit/Poster Hall, South Building, Level 1
*This abstract was also selected as a Reviewers’ Choice Abstract as reviewers scored it in the top 10% of poster abstracts.
3D genomics with Arima Hi-C sequencing enables detection of clinically relevant gene fusions in pediatric cancer samples
Kristin Sikkink, PhD, Senior Scientist
Wednesday, October 26 | 3:00 pm – 4:45 pm
Poster Location: PB1001 | Exhibit/Poster Hall, South Building, Level 1
Meet the Speakers:
Anthony Schmitt, PhD
SVP, Science at Arima GenomicsAnthony Schmitt, PhD has led the development of the core Arima Hi-C chemistry and technology platform since Arima’s inception, contributed to core inventions and technology development grants, and continues to lead the R&D programs for targeted chromosome conformation capture techniques.
Kristin Sikkink, PhD
Senior Scientist at Arima GenomicsDr. Kristin Sikkink is a Senior Scientist in Scientific Affairs and holds a PhD in Biology. At Arima Genomics, she spearheads research and development initiatives.